Table 1.
Characteristics, clinical history, and symptomatology of recruited patients with post-COVID-19 syndrome (n = 32).
| Variable | Variable | ||
|---|---|---|---|
| Age (years) | 44.7 ± 10.9 | Total mean symptoms (n) | 6.8 ± 3.3 |
| Sex (n) | Symptom’s length (weeks) | 23.1 ± 13.6 | |
| Male | 10 (31.3) | Symptoms | |
| Female | 22 (68.8) | Fatigue | 26 (81.3) |
| Body composition | Dyspnea | 18 (56.3) | |
| Body mass (kg) | 72.3 ± 14.8 | Lack of concentration | 18 (56.3) |
| Height (m) | 1.66 ± 0.10 | Memory problems or confusion | 17 (53.1) |
| BMI (kg·m−2) | 26.0 ± 4.4 | Low mood | 17 (53.1) |
| Fat mass (%) | 30.6 ± 8.3 | Brain fog | 17 (53.1) |
| Lean body mass (kg) | 49.9 ± 11.6 | Insomnia or sleep disturbances | 17 (53.1) |
| Comorbidity (n) | Headache | 13 (40.6) | |
| Psychiatric conditions | 12 (37.5) | Myalgia | 10 (31.3) |
| Asthma | 5 (15.6) | Anxiety | 10 (31.3) |
| Hypertension | 2 (6.3) | Loss of smell/taste | 9 (28.1) |
| Structural heart disease | 2 (6.3) | Hair loss | 8 (25.0) |
| COPD | 1 (3.1) | Chest pain | 8 (25.0) |
| Diabetes | 1 (3.1) | Dizziness | 7 (21.9) |
| Toxic habits (n) | Low-grade fever | 7 (21.9) | |
| Alcohol | 3 (9.4) | Palpitations | 5 (15.6) |
| Active smoker | 2 (6.3) | Weight loss | 5 (15.6) |
| Former smoker | 9 (28.1) | Cough | 4 (12.5) |
| Medication (n) | Diarrhea | 4 (12.5) | |
| Taking medication | 25 (78.1) | Abdominal pain | 3 (9.4) |
| Antidepressants | 13 (40.6) | Loss appetite | 3 (9.4) |
| Benzodiazepines | 11 (34.4) | Nausea and/or vomiting | 2 (6.3) |
| Bronchodilators | 7 (21.9) | Evolution | |
| Fluctuating course | 19 (59.4) | ||
| Progressive improvement | 23 (71.9) |
Data are means and standard deviations (M ± SD) or frequencies and percentages (n (%)). COPD: chronic obstructive pulmonary disease.